Condom distribution in jail to prevent HIV infection

AIDS and Behavior

Volumn 17, Issue 8, 2013, Pages 2695-2702

  Leibowitz, Arleen A ^a   Harawa, Nina ^b   Sylla, Mary ^c   Hallstrom, Christopher C ^d   Kerndt, Peter R ^e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c Division of Public Health Foundation Enterprise Inc   (United States)

^d UNIVERSITY OF PORTLAND   (United States)

^e LOS ANGELES COUNTY DEPARTMENT OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Condom; HIV; Jail; Public costs

Indexed keywords

ADULT; ARTICLE; CONDOM; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MALE HOMOSEXUALITY; PREVALENCE; PRISON; PRISONER; PROGRAM EVALUATION; SEXUALITY; UNITED STATES; UTILIZATION REVIEW;

ADULT; CONDOMS; COST-BENEFIT ANALYSIS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; LOS ANGELES; MALE; PREVALENCE; PRISONERS; PRISONS; PROGRAM EVALUATION; SEXUAL PARTNERS;

EID: 84885424537     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-012-0190-5     Document Type: Article

References (34)

1. Office of National AIDS Strategy. National HIV/AIDS strategy for the United States. July 2010.
2. CDC, Division of HIV/AIDS Prevention. Condom distribution as a structural level intervention. October 2010. www.cdc.gov/hiv. Accessed 1 Feb 2011.
3. Seal DW, Margolis AD, Morrow KM, et al. Substance use and sexual behavior during incarceration among 18- to 29-year old men: prevalence and correlates. AIDS Behav. 2008;12(1):27-40.
4. Johnson RC, Raphael S. The effects of male incarceration dynamics on acquired immune deficiency syndrome infection rates among African American women and men. J Law Econ. 2009;52(2):251-93.
5. Krebs CP, Simmons M. Intraprison HIV transmission: an assessment of whether it occurs, how it occurs, and who is at risk. AIDS Educ Prev. 2002;14(5 Suppl B):53-64.
6. Centers for Disease Control and Prevention (CDC). HIV transmission among male inmates in a state prison system - Georgia, 1992-2005. Morb Mortal Wkly Rep. 2006;55:421-6.
7. Sylla M, Harawa N, Grinsted-Reznick O. The first condom machine in a US jail: the challenge of harm reduction in a law and order environment. Am J Public Health. 2010;100:982-5.
8. Shuter J. Communicable diseases in inmates: public health opportunities. In: Health care for soon-to-be-released inmates: a report to congress. vol. 2. Chicago: National Commission on Correctional Health Care; 2002.
9. Bureau of Justice Statistics. Corrections facts at a glance. http://www.ojp.usdoj.gov/bjs/glance/corr2.htm. Accessed 14 Dec 2009.
10. Sabol WJ, West HC, Cooper M. Prisoners in 2008. Washington: US Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2009.
11. Minton TD, Sabol WJ. Jail inmates at midyear 2008 - statistical tables. Washington: US Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2009.
12. Braithwaite RL, Arriola KR. Male prisoners and HIV prevention: a call for action ignored. Am J Public Health. 2003;93(5):759-63.
13. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. J Am Med Assoc. 2008;300(5):520-9.
14. Jenness V, Maxson CL, Matsuda KN, Sumner JM. Violence in California correctional facilities: an empirical examination of sexual assault. Bulletin. vol. 2. no. 2. Irvine: UC Irvine Center for Evidence-Based Corrections; 2007. p. 1-4.
15. Moseley K, Tewksbury R. Prevalence and predictors of HIV risk behaviors among male prison inmates. J Correct Health Care. 2006;12(2):132-44.
16. Wohl AR, Johnson D, Jordan W, et al. High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr. 2000;24(4):386-92.
17. Javanbakht M, Murphy R, Harawa NT, et al. Sexually transmitted infections and HIV prevalence among incarcerated men who have sex with men, 2000-2005. Sex Transm Dis. 2009;36(2):S17-21.
18. Harawa NT, Sweat J, George S, Sylla M. Sex and condom use in a large jail unit for men who have sex with men (MSM) and male-to-female transgenders. J Health Care Poor Underserv. 2010;21(3):1071-87.
19. Knox L, Lane C. CorrectHELP condom survey uncorrected summary report. 14 Dec 2005.
20. Yap L, Butler T, Richtus J, Kirkwood K, Grant L, Saxby M, Ropp F, Donovan B. Do condoms cause rape and mayhem? The long-term effects of condoms in New South Wales prisons. Sex Transm Infect. 2007;83(3):219-22.
21. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacWueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol. 1999;150(3):306-11.
22. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR, Moore RD, Freedberg KA. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care. 2006;44(11):990-7.
23. US Census Bureau. Consumer price indexes (CPI-U) by major groups: 1990-2009. Washington: Statistical Abstract of the United States, 2011. http://www.census.gov/compendia/statab/2011/tables/11s0724.pdfAccessed. Accessed 1 June 2011.
24. Pinkerton SD, Holtgrave DR, DiFranceisco W, Semaan S, Coyle SL, Johnson-Masotti AP. Cost-threshold analyses of the National AIDS Demonstration Research HIV prevention interventions. AIDS. 2000;14:1257-68.
25. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med. 1997;44:1303-12.
26. Weller SC. A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med. 1993;36:1635-44.
27. Pinkerton SD, Holtgrave DR. A method for evaluating the economic efficiency of HIV behavioral risk reduction interventions. AIDS Behav. 1998;2(3):189-201.
28. Katz MH, Gerberding JL. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. N Eng J Med. 1997;15(336):1087-100.
29. Pinkerton SD, Holtgrave DR, Bloom FR. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. AIDS. 1998;12(9):1067-78.
30. Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol. 2010;39(4):1048-63.
31. Pinkerton SD, Chesson HW, Holtgrave DR, Kassler W, Layde PM. When is an HIV infection prevented and when is it merely delayed? Eval Rev. 2000;24:251-71.
32. Mastro TD, de Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS. 1996;10(Suppl. A):S75-82.
33. Philip SS, Yu X, Donnell D, Vittinghoff E, Buchbinder S. Serosorting is associated with a decreased risk of HIV seroconversion in the EXPLORE Study Cohort. PLoS One. 2010;5(9):e12662.
34. Attia S, Egger M, Muller M, Zwahlen M, Low M. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23(11):1397-404.